MXPA03007433A - Pirazolil pirimidinas. - Google Patents

Pirazolil pirimidinas.

Info

Publication number
MXPA03007433A
MXPA03007433A MXPA03007433A MXPA03007433A MXPA03007433A MX PA03007433 A MXPA03007433 A MX PA03007433A MX PA03007433 A MXPA03007433 A MX PA03007433A MX PA03007433 A MXPA03007433 A MX PA03007433A MX PA03007433 A MXPA03007433 A MX PA03007433A
Authority
MX
Mexico
Prior art keywords
pyrimidines
pyrazolyl
pyrazolyl pyrimidines
Prior art date
Application number
MXPA03007433A
Other languages
English (en)
Spanish (es)
Inventor
Christoph Erdelen
Original Assignee
Bayer Cropscience Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Cropscience Ag filed Critical Bayer Cropscience Ag
Publication of MXPA03007433A publication Critical patent/MXPA03007433A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MXPA03007433A 2001-02-22 2002-02-11 Pirazolil pirimidinas. MXPA03007433A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10108480A DE10108480A1 (de) 2001-02-22 2001-02-22 Pyrazolylpyrimidine
PCT/EP2002/001400 WO2002068413A1 (de) 2001-02-22 2002-02-11 Pyrazolylpyrimidine

Publications (1)

Publication Number Publication Date
MXPA03007433A true MXPA03007433A (es) 2003-11-18

Family

ID=7675081

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03007433A MXPA03007433A (es) 2001-02-22 2002-02-11 Pirazolil pirimidinas.

Country Status (13)

Country Link
US (1) US7087616B2 (https=)
EP (1) EP1363905A1 (https=)
JP (1) JP2004524315A (https=)
KR (1) KR100854583B1 (https=)
CN (1) CN1301992C (https=)
BR (1) BR0207509A (https=)
DE (1) DE10108480A1 (https=)
HU (1) HUP0303241A2 (https=)
IL (1) IL157298A0 (https=)
MX (1) MXPA03007433A (https=)
TW (1) TWI236475B (https=)
WO (1) WO2002068413A1 (https=)
ZA (1) ZA200306468B (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI372050B (en) * 2003-07-03 2012-09-11 Astex Therapeutics Ltd (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
EP1833819A1 (en) 2004-12-30 2007-09-19 Astex Therapeutics Limited Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases
DE102005058418A1 (de) * 2005-12-07 2007-06-21 Bayer Cropscience Gmbh Verfahren zur Herstellung von Haloalkyl(thio)vinimidiniumsalzen und 4-(Haloalkyl(thio))-pyrazolen und deren Umsetzung zu Pflanzenschutzmitteln
EP1968579A1 (en) * 2005-12-30 2008-09-17 Astex Therapeutics Limited Pharmaceutical compounds
WO2008001101A2 (en) * 2006-06-29 2008-01-03 Astex Therapeutics Limited Pharmaceutical combinations
EP2049119A2 (en) * 2006-06-29 2009-04-22 Astex Therapeutics Limited Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morphoolin-4-ylmethyl-1h-benzoimidazol-2-yl)-1h-1-pyrazol-4-yl]-urea
DE102007003036A1 (de) * 2006-12-20 2008-06-26 Bayer Cropscience Ag Pyrimidinylpyrazole
DE102007044032A1 (de) 2007-09-14 2009-03-19 Bayer Healthcare Ag Substituierte heterocyclische Verbindungen und ihre Verwendung
DE102007048447A1 (de) 2007-10-10 2009-04-16 Bayer Healthcare Ag Substituierte Dihydropyrazolthione und ihre Verwendung
EP2135865A1 (de) * 2008-06-17 2009-12-23 Bayer CropScience AG Substituierte 1-(Diazinyl) pyrazol-4-yl-essigsäuren, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
CN102186809A (zh) * 2008-08-14 2011-09-14 拜尔农作物科学股份公司 杀虫性的4-苯基-1h-吡唑
KR20120027265A (ko) 2009-04-27 2012-03-21 다우 아그로사이언시즈 엘엘씨 살충성 피리딘 화합물
WO2011045224A1 (de) * 2009-10-12 2011-04-21 Bayer Cropscience Ag 1- (pyrid-3-yl) -pyrazole und 1- (pyrimid-5-yl) -pyrazole als schädlingsbekämpfungsmittel
AR078947A1 (es) 2009-11-11 2011-12-14 Bayer Cropscience Ag Compuestos de diazinil-pirazolilo y procesos de preparacion de los mismos
JP2012116796A (ja) * 2010-12-01 2012-06-21 Sumitomo Chemical Co Ltd ヘテロ芳香環化合物およびその有害生物防除用途
KR20140138293A (ko) 2012-03-16 2014-12-03 액시킨 파마수티컬스 인코포레이티드 3,5-다이아미노피라졸 키나아제 억제제
NZ631142A (en) 2013-09-18 2016-03-31 Axikin Pharmaceuticals Inc Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
HRP20220522T1 (hr) 2014-08-04 2022-06-10 Nuevolution A/S Proizvoljno kondenzirani heterociklil-supstituirani derivati pirimidina koji su korisni za liječenje upalnih, metaboličkih, onkoloških i autoimunih bolesti
US10118890B2 (en) 2014-10-10 2018-11-06 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
US9546163B2 (en) 2014-12-23 2017-01-17 Axikin Pharmaceuticals, Inc. 3,5-diaminopyrazole kinase inhibitors
US11685727B2 (en) 2019-12-20 2023-06-27 Nuevolution A/S Compounds active towards nuclear receptors
MX2022007265A (es) 2019-12-20 2022-09-09 Nuevolution As Compuestos activos frente a receptores nucleares.
CA3174176A1 (en) 2020-03-31 2021-10-07 Sanne Schroder Glad Compounds active towards nuclear receptors
EP4126874A1 (en) 2020-03-31 2023-02-08 Nuevolution A/S Compounds active towards nuclear receptors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910910A (en) * 1972-03-31 1975-10-07 American Home Prod (2-Pyrimidinylthio) alkanoic acids, esters, amides and hydrazides
US4663327A (en) * 1984-05-23 1987-05-05 Bayer Aktiengesellschaft 1-heteroaryl-4-aryl-pyrazolin-5-ones
EP0702670A1 (de) 1993-06-07 1996-03-27 Bayer Ag Iodpropargylcarbamate und ihre verwendung als biozide im pflanzen- und materialschutz
CN1153779A (zh) * 1995-09-28 1997-07-09 山道士有限公司 2-(4-吡唑基氧基-嘧啶-5-基)乙酸衍生物
EP0967212A4 (en) 1996-12-16 2002-01-09 Sumitomo Chemical Co PYRAZOLINE COMPOUNDS AND THEIR USE AS A MEANS FOR CONTROLLING PLANT DISEASES

Also Published As

Publication number Publication date
TWI236475B (en) 2005-07-21
IL157298A0 (en) 2004-02-19
CN1492864A (zh) 2004-04-28
HUP0303241A2 (hu) 2004-01-28
DE10108480A1 (de) 2002-09-05
JP2004524315A (ja) 2004-08-12
KR100854583B1 (ko) 2008-08-27
EP1363905A1 (de) 2003-11-26
BR0207509A (pt) 2004-03-09
WO2002068413A1 (de) 2002-09-06
CN1301992C (zh) 2007-02-28
KR20030075188A (ko) 2003-09-22
US20040102465A1 (en) 2004-05-27
ZA200306468B (en) 2005-02-04
US7087616B2 (en) 2006-08-08

Similar Documents

Publication Publication Date Title
MXPA03007433A (es) Pirazolil pirimidinas.
ZA200306530B (en) Foamer.
MXPA03007166A (es) Pirido-pirimidinas 6-sustituidas.
ZA200208561B (en) Hydraulischer druckverstarker.
MXPA01009037A (es) I-bet.
MXPA03007320A (es) Nuevos compuestos de pirimidina.
ZA200208648B (en) Metal-polyurethane laminates.
MXPA03005286A (es) METODO Y APARATO PARA SUPERVISAR PULSACION DE INSTALACION DE ORDEnA.
MXPA03008140A (es) Amidas de acido benzofuran-2-carboxilico sustituidas.
MXPA03005302A (es) Solucion acuosa para remover pintura.
MXPA03008139A (es) Fluoralcoxifenilsulfonilureas sustituidas.
MXPA03004453A (es) Derivados de pirimidina.
MXPA03009073A (es) Altavoz.
MXPA03008394A (es) Derivados de biuretano.
MXPA03004242A (es) Nuevas fenilpiperazinas.
MXPA03000504A (es) Derivados de pirimidina.
MXPA03007888A (es) Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos.
ZA200200597B (en) Combination theraphy.
GB0203683D0 (en) PAK-GFP Construct
AU2002231792A1 (en) Pyrazolyl pyrimidines
ZA200200419B (en) Communication system.
GB0119932D0 (en) G.l.g.
GB0112068D0 (en) Greensnail . com
ZA200208820B (en) Foamer unit.
AP2001000098S (en) Marimbira.

Legal Events

Date Code Title Description
FG Grant or registration